Lidocaine And Prilocaine Cream
Product Images NDC 0168-0357

11 FDA label images from E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lidocaine And Prilocaine (NDC 0168-0357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E. Fougera & Co. A Division Of Fougera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Lido Prilo 01)

Chemical-structure (Lido Prilo 01)
Chemical structure of lidocaine, showing its molecular formula C14H22N2O and molecular weight of 234.3. The diagram depicts the arrangement of atoms and bonds for the local anesthetic ingredient in the Lidocaine and Prilocaine cream topical product by E. Fougera & Co.*
FDA Label Image

Chemical-structure (Lido Prilo 02)

Chemical-structure (Lido Prilo 02)
Chemical structure diagram showing the molecular formula C13H20N2O with molecular weight 220.3, corresponding to the active ingredient lidocaine in the Lidocaine and Prilocaine cream product.*
FDA Label Image

Figure-1 (Lido Prilo 03)

Figure-1 (Lido Prilo 03)
An instructional illustration showing a person applying cream onto the skin. The image depicts hands squeezing cream from a tube and spreading it on the skin, indicating topical use.*
FDA Label Image

Figure-2 (Lido Prilo 04)

Figure-2 (Lido Prilo 04)
An instructional illustration depicting two hands opening a foil pouch by peeling it apart, demonstrating the method to access the contents inside.*
FDA Label Image

Figure-3 (Lido Prilo 05)

Figure-3 (Lido Prilo 05)
An instructional illustration showing a hand peeling back the protective foil of a tube or packet, likely demonstrating how to open the product packaging for a topical cream such as lidocaine and prilocaine cream.*
FDA Label Image

Figure-4 (Lido Prilo 06)

Figure-4 (Lido Prilo 06)
An instructional illustration showing a hand holding a foil packet of Lidocaine and Prilocaine 25 mg/g topical cream. The image depicts the action of squeezing the cream out of the packet, indicating how to open and use the single-dose packet.*
FDA Label Image

Figure-5 (Lido Prilo 07)

Figure-5 (Lido Prilo 07)
An instructional line drawing illustrating the application of topical cream to the skin around the eye area. The image shows a hand applying cream near the eye, highlighting careful placement on the skin.*
FDA Label Image

Figure-6 (Lido Prilo 08)

Figure-6 (Lido Prilo 08)
An instructional line drawing showing the application of a topical cream on skin. The image depicts a hand spreading cream on a rounded surface, likely representing a medical or anatomical site for topical treatment.*
FDA Label Image

30g-carton (Lido Prilo 09)

30g-carton (Lido Prilo 09)
Packaging label for Lidocaine and Prilocaine Cream 2.5%/2.5%, topical cream by E. Fougera & Co., a division of Fougera Pharmaceuticals, LLC. The label indicates a net weight of 30 grams, includes a barcode, and warnings such as 'Not for ophthalmic use' and 'For external use only.' Instructions for use, storage, and pharmacist notes are also present on the label.*
FDA Label Image

5g-carton-with-dressings (Lido Prilo 10)

5g-carton-with-dressings (Lido Prilo 10)
Packaging label for Lidocaine and Prilocaine Cream, 2.5% / 2.5%, a topical cream by E. Fougera & Co. This box contains 5 tubes of 5 grams each and holds 12 dressings. The label includes storage instructions, usage notes, and warnings such as 'Not for ophthalmic use' and 'For external use only.' Product NDC 0168-0357-56 is shown along with manufacturer details and barcode.*
FDA Label Image

5g-carton-without-dressings (Lido Prilo 11)

5g-carton-without-dressings (Lido Prilo 11)
Lidocaine and Prilocaine Cream, 2.5% / 2.5% packaging label for topical prescription drug by E. Fougera & Co., a division of Fougera Pharmaceuticals, LLC. The label states it contains 5 tubes of 5 grams each, is for hospital use only, and instructs application with an occlusive dressing. Storage and opening instructions are included, with warnings against ophthalmic use and for external use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.